PCA0001
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
W |
<NA>
|
<NA>
|
|
Metadata
|
|
|
PCA0003
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
H5a1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
PCA0004
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
U3a1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12300A (MT-TL2): 3243 suppressor mutant (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
14258A (MT-ND6): LHON synergistic combo 10680A + 12033G + 14258A also combo 14258A + 14582G (Reported: individually neutral variants causing LHON in combination)
-
15024A (MT-CYB): Possible DEAF modifier (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15153A (MT-CYB): Suspected mito disease (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
3460A (MT-ND1): LHON (Cfrm)
|
PCA0006
|
MAPl |
Middle Ages |
Poland |
F |
80 |
120 |
U5a1d1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
14459A (MT-ND6): LDYT / Leigh Disease / dystonia / carotid atherosclerosis risk (Cfrm)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
4320T (MT-TI): Mitochondrial Encephalocardiomyopathy (Reported)
-
4327C (MT-TI): Ataxia+ / with RRF and COX deficiency (Reported)
-
5532A (MT-TW): Gastrointestinal Syndrome (Reported)
|
PCA0007
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
W1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
3635A (MT-ND1): LHON (Cfrm)
-
4450A (MT-TM): Myopathy / MELAS / Leigh Syndrome (Cfrm)
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
PCA0015
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
H1f1a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
PCA0026
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
T2b16 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
1310T (MT-RNR1): DEAF-associated (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
PCA0030
|
MAPl |
Middle Ages |
Poland |
F |
110 |
160 |
H2a2b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
|
PCA0031
|
MAPl |
Middle Ages |
Poland |
F |
10 |
375 |
K2a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
PCA0036
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
U5b1d1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
869T (MT-RNR1): found in 1 HCM patient (Reported)
|
PCA0041
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
N |
<NA>
|
<NA>
|
|
Metadata
|
|
|
PCA0044
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
H5a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
2835T (MT-RNR2): Rett Syndrome (Reported)
-
4336C (MT-TQ): ADPD / Hearing Loss & Migraine / autism spectrum / intellectual disability (Unclear)
|
PCA0045
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
U5b1d1 |
<NA>
|
<NA>
|
|
Metadata
|
|
|
PCA0046
|
MAPl |
Middle Ages |
Poland |
M |
110 |
160 |
U8a1a1b |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
|
PCA0047
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
H5a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
4336C (MT-TQ): ADPD / Hearing Loss & Migraine / autism spectrum / intellectual disability (Unclear)
|
PCA0049
|
MAPl |
Middle Ages |
Poland |
F |
110 |
160 |
H1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
PCA0051
|
MAPl |
Middle Ages |
Poland |
F |
110 |
160 |
K2a |
<NA>
|
<NA>
|
|
Metadata
|
|
|
PCA0054
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
U3a1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16390A (MT-CR): POAG - potential for association (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
6285A (MT-CO1): Prostate Cancer (Reported)
-
8328A (MT-TK): Mito Encephalopathy / EXIT with myopathy and ptosis (Reported)
|
PCA0056
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
T2b6a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
15928A (MT-TT): Multiple Sclerosis / idiopathic repeat miscarriage / AD protection (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
4917G (MT-ND2): LHON / Insulin Resistance / AMD / NRTI-PN (Reported)
|
PCA0057
|
MAPl |
Middle Ages |
Poland |
F |
110 |
160 |
J1c7a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
185A (MT-CR): Low VO2max response (Reported)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
PCA0060
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
U5b1d1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16192T (MT-CR): Melanoma patients (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
|
PCA0061
|
MAPl |
Middle Ages |
Poland |
U |
80 |
260 |
H1ak |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
PCA0063
|
MAPl |
Middle Ages |
Poland |
M |
10 |
375 |
H2a5 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
|
PCA0002
|
MAPl |
Middle Ages |
Poland |
M |
10 |
375 |
H28a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
5698A (MT-TN): CPEO / MM (Reported)
-
5703A (MT-TN): CPEO / MM (Cfrm)
-
6150A (MT-CO1): Prostate Cancer / enriched in POAG cohort (Reported)
-
7453A (MT-TS1): Fatal neonatal lactic acidosis / Neonatal lactic acidosis / exercise intolerance / mild ID (Reported)
|
PCA0013
|
MAPl |
Middle Ages |
Poland |
U |
80 |
260 |
J1c3 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
295T (MT-CR): Low VO2max response (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
228A (MT-CR): Low VO2max response (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
462T (MT-CR): Low VO2max response (Reported)
-
489C (MT-CR): Low VO2max response (Reported)
|
PCA0027
|
MAPl |
Middle Ages |
Poland |
M |
80 |
120 |
H1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
PCA0029
|
MAPl |
Middle Ages |
Poland |
U |
10 |
375 |
X2c1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
|
PCA0032
|
MAPl |
Middle Ages |
Poland |
F |
80 |
120 |
T2n |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
13637G (MT-ND5): Possible LHON factor (Reported)
-
3460A (MT-ND1): LHON (Cfrm)
|
PCA0034
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
K2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
PCA0035
|
MAPl |
Middle Ages |
Poland |
M |
80 |
120 |
J2b1a5 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11251G (MT-ND4): Reduced risk of PD (Reported)
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
15812A (MT-CYB): LHON (Reported / Secondary)
-
295T (MT-CR): Low VO2max response (Reported)
-
4216C (MT-ND1): LHON / Insulin Resistance /possible adaptive high altitude variant / miscarriage (Conflicting reports)
-
489C (MT-CR): Low VO2max response (Reported)
|
PCA0037
|
MAPl |
Middle Ages |
Poland |
M |
10 |
375 |
T2e |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
1624T (MT-TV): Leigh Syndrome (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
PCA0040
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
I4a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
12705T (MT-CO1): Possible protective factor for normal tension glaucoma (Reported)
-
15043A (MT-CYB): MDD-associated (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16129A (MT-CR): Cyclic Vomiting Syndrome with Migraine (Reported)
-
8519A (MT-ATP8): Susceptibility to bullous pemphigoid (Reported)
|
PCA0053
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
K1b2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
10398G (MT-ND3): PD protective factor / longevity / altered cell pH / metabolic syndrome / breast cancer risk / Leigh Syndrome risk / ADHD / cognitive decline / SCA2 age of onset / Fuchs endothelial corneal dystrophy (Reported / lineage L & M marker / also hg IJK)
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
5913A (MT-CO1): Prostate Cancer / hypertension (Reported)
|
PCA0062
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
U4a2 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15693C (MT-CYB): Possibly LVNC cardiomyopathy-associated (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
-
310C (MT-CR): Possible protective factor for normal tension glaucoma (Reported)
-
499A (MT-CR): Endometriosis (Reported)
|
PCA0018
|
MAPl |
Middle Ages |
Poland |
M |
10 |
375 |
HV18 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
7554A (MT-TD): Myopathy+ataxia+nystagmus+migraines+lactic acidosis (Reported)
-
8340A (MT-TK): Myopathy / Exercise Intolerance / Eye disease+SNHL (Cfrm)
-
8342A (MT-TK): PEO and Myoclonus (Reported)
|
PCA0028
|
MAPl |
Middle Ages |
Poland |
F |
80 |
260 |
U3a1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
150T (MT-CR): Longevity / Cervical Carcinoma / HPV infection risk (Conflicting reports)
-
16390A (MT-CR): POAG - potential for association (Reported)
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
|
PCA0038
|
MAPl |
Middle Ages |
Poland |
U |
80 |
260 |
H1e1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
PCA0050
|
MAPl |
Middle Ages |
Poland |
M |
80 |
260 |
H1e1a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
3010A (MT-RNR2): Cyclic Vomiting Syndrome with Migraine / high altitude disease risk factor (Reported)
-
5460A (MT-ND2): AD / PD / LHON (Conflicting reports)
|
PCA0052
|
MAPl |
Middle Ages |
Poland |
F |
110 |
160 |
U5a1a1 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
15924G (MT-TT): LIMM (Reported)
-
16270T (MT-CR): Melanoma patients (Reported)
-
195C (MT-CR): BD-associated / melanoma pts (Reported)
|
PCA0059
|
MAPl |
Middle Ages |
Poland |
F |
110 |
160 |
K2a |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11467G (MT-ND4): Altered brain pH / sCJD patients (Reported)
-
12308G (MT-TL2): CPEO / Stroke / CM / Breast & Renal & Prostate Cancer Risk / Altered brain pH /sCJD (Reported)
-
12372A (MT-ND5): Altered brain pH / sCJD patients (Reported)
-
146C (MT-CR): Absence of Endometriosis (Reported)
-
9055A (MT-ATP6): PD protective factor (Reported)
|
PCA0066
|
MAPl |
Middle Ages |
Poland |
M |
80 |
120 |
H2a5 |
bam
|
<NA>
|
|
FASTA
Metadata
|
|
-
11150A (MT-ND4): Found in a Multiple Sclerosis patient (Reported)
-
13708A (MT-ND5): LHON / Increased MS risk / higher freq in PD-ADS (Conflicting reports)
|